for isosorbide dinitrate and isosorbide 5-mononitrate , as well as for transdermal nitroglycerin systems , interval treatment dosing regimens with maintained effectiveness documented in controlled studies have been delineated .
C0022252
isosorbide dinitrate
C0064079
isosorbide